Roger Li MDGenitourinary Oncologist, Moffitt Cancer Center, Tampa, Florida
Dr. Roger Li is a genitourinary oncologist whose clinical practice focuses on the surgical treatment of bladder, prostate, kidney and penile cancers. He offers a variety of treatment options, including open, laparoscopic, and robotic-assisted procedures, as well as nerve sparing approaches based on the clinical scenario. Prior to joining Moffitt, Dr. Li completed advanced urologic oncology training at the MD Anderson Cancer Center in Houston, Texas. Dr. Li’s research interest includes the genomic characterization of genitourinary malignancies in attempt to tailor therapy specific to the patient, as well as the development of novel immunotherapeutic strategies in treating early stage bladder cancer. Dr. Li’s work has previously been highlighted in several national and international urology meetings. He has authored numerous peer reviewed manuscripts and book chapters on urologic oncology. In addition, he serves as reviewer for many international urologic journals, including British Journal of Urology International, European Urology Oncology, Journal of Clinical Genitourinary Cancer, and BMC Cancer.
Disclosures: RL: Clinical trial protocol committee – CG Oncology; Scientific advisor/consultant – BMS, Ferring, Fergene, Arquer Diagnostics